tipapkinogene sovacivec,avelumab
transgene,Merck,Pfizer
['tg4001', 'transgene', '$tng']
transgene $tng presents immunological data demonstrating that tg4001, a novel therapeutic cancer vaccine, can induce t-cell responses against hpv16 antigens in the ongoing phase ii trial at asco 2023 - 
Business Intelligence on European listed biotech companies
Subscription Plan now available for retail customers